Private equity: The booming biotech sector
Investment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment in the first half of 2020, according to data from funds trade body Invest Europe. Investors in the field are faced not only with financial and ethical dilemmas, but the risks posed by the presence […]
Private equity and biotechnology: Michael Johnson talks about the role investors play in the development of the biotech industry
Michael Johnson, group head of institutional services at fund administrator Crestbridge, talks to Funds Europe about the role investors play in the development of the biotech industry. What due diligence must private equity funds carry out when investing in biotechnology? With a high degree of interest in biotechnology even before the pandemic hit, private funds […]
